
Protocol doesn't address all aims of phase IV CT: CDSCO Panel Tells Sun Pharma Lab on Esomeprazole Dual Release Gastro ...
New Delhi: Citing that the proposed study protocol of Esomeprazole Dual Release GastroResistant Tablets 80mg does not address all the aims of the phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control …